Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Crash at Sierra Highway and Robinsong Road Causes Major Injuries


2 Vehicles Collide in Santa Clarita Accident

Santa Clarita, CA (April 7, 2020) – A crash in Santa Clarita has caused major injuries. The accident occurred on the morning of April 7 at Sierra Highway and Robinsong Road.

A Toyota Prius and a Toyota 4Runner collided at the intersection for unknown reasons. Those involved suffered major injuries. The roads were closed for an hour.

#Santa Clarita

#91390


May 13, 2020

1 Injured in Hit and Run Crash at Broadway and F Street

Car Hits Pedestrian in Parking Lot in Chula Vista Accident...


April 9, 2020

Motorcyclist Injured in Crash on Highway 1 Near Pomponio State Beach

Motorcycle, SUV Collide in San Gregorio Accident...


November 5, 2019

1 Injured in Crash on State Route 67 Near Dye Road

Car Hits Tree in Ramona Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.